A Risk Signature Consisting of Eight m6A Methylation Regulators Predicts the Prognosis of Glioma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Cellular and Molecular Neuroscience,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s10571-021-01135-x.pdf
Reference42 articles.
1. Allahverdi A, Arefian E, Soleimani M, Ai J, Nahanmoghaddam N, Yousefi-Ahmadipour A, Ebrahimi-Barough S (2020) MicroRNA-4731–5p delivered by AD-mesenchymal stem cells induces cell cycle arrest and apoptosis in glioblastoma. J Cell Physiol. https://doi.org/10.1002/jcp.29472
2. Bell JL, Wachter K, Muhleck B, Pazaitis N, Kohn M, Lederer M, Huttelmaier S (2013) Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression? Cell Mol Life Sci 70:2657–2675. https://doi.org/10.1007/s00018-012-1186-z
3. Bhat K et al (2020) The dopamine receptor antagonist trifluoperazine prevents phenotype conversion and improves survival in mouse models of glioblastoma. Proc Natl Acad Sci U S A 117:11085–11096. https://doi.org/10.1073/pnas.1920154117
4. Chai RC et al (2019) m(6)A RNA methylation regulators contribute to malignant progression and have clinical prognostic impact in gliomas. Aging (albany NY) 11:1204–1225. https://doi.org/10.18632/aging.101829
5. Cheng J, Meng J, Zhu L, Peng Y (2020) Exosomal noncoding RNAs in Glioma: biological functions and potential clinical applications. Mol Cancer 19:66. https://doi.org/10.1186/s12943-020-01189-3
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Emerging Roles and Mechanisms of RNA Modifications in Neurodegenerative Diseases and Glioma;Cells;2024-03-05
2. m6A mRNA Modifications in Glioblastoma: Emerging Prognostic Biomarkers and Therapeutic Targets;Cancers;2024-02-09
3. IGF2BP2 promotes glycolysis and hepatocellular carcinoma stemness by stabilizing CDC45 mRNA via m6A modification;Cell Cycle;2023-10-18
4. HOXD‐AS2‐STAT3 feedback loop attenuates sensitivity to temozolomide in glioblastoma;CNS Neuroscience & Therapeutics;2023-06-12
5. Understanding the Epitranscriptome for Avant-Garde Brain Tumour Diagnostics;Cancers;2023-02-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3